Anyone have any insights into this group? Growth, exit ops, reputation?
Looking to move into a restructuring role (currently audit at B4 in the South) and am speaking with some of the big 3 Rx names, as well as Ankura. Seems like they’ve won some bigger deals in recent years and would love some insight from someone who’s in the Rx business already.
Cheers!
Hi TnRDude, check out these threads:
More suggestions...
Hope that helps.
Currently in industry, and it's a brand name in RX. Firms like Ankura would be the close equivalent of "elite boutiques" in the RX consulting world, with a few others that generally compete for the same mandates including Conway, BRG, Province.
Can't see ankura beating a&m in anything that a&m is interested in. What would be their proposition?
Arent they basically bunch of ex Fti people? The bottom of the 3 Rx shops...
What are your thoughts on province?
I would say they are a step below other big names in the rx consulting world; hardly see them on public mandates (though that doesn’t mean they don’t land them)
Would you say a jump from B4 audit to this group is a solid move?
Anything that isn't financial accounting or financial reporting (or tax) is
Odio maxime facilis qui fugit minus. Molestiae dolorem molestiae reprehenderit dignissimos qui excepturi. Aut molestias dolorem et maxime. Repudiandae expedita dolor tempora minus dolorem.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...